Home > Gastroenterology > Lymph node ratio helpful for adjuvant-chemo planning in gastric cancer

Lymph node ratio helpful for adjuvant-chemo planning in gastric cancer


Notice: Undefined index: new_doi_fields in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22

Notice: Trying to access array offset on value of type null in /home/daan/projects/medicalconferences_dev/wp-content/themes/writers-blogily-child/template-parts/content-structured.php on line 22
Journal
JAMA Network Open
Reuters Health - 11/04/2022 - In patients with locally advanced gastric cancer (LAGC), the lymph node ratio (LNR) has value in determining which patients benefit from adjuvant chemotherapy (AC), a new study suggests.  The researchers found that receipt of AC after neoadjuvant chemotherapy (NAC) and curative-intent gastrectomy was associated with improved prognosis in patients with LNR of 9% or greater.  Whether AC can improve the outcome of patients with LAGC after NAC remains a matter of debate, say Dr. Jian-Xian Lin with Fujian Medical University Union Hospital in China and colleagues in JAMA Network Open.


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on